The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Plains Exploration & Production Company (PXP), Intermec Inc. (IN), TNS, Inc. (TNS) and Somaxon Pharmaceuticals, Inc. (SOMX)

Wednesday, December 12, 2012

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Plains Exploration & Production Company (PXP), Intermec Inc. (IN), TNS, Inc. (TNS) and Somaxon Pharmaceuticals, Inc. (SOMX)10:59 EST Wednesday, December 12, 2012NEW YORK, Dec. 12, 2012 /PRNewswire/ -- Plains Exploration & Production Company Levi & Korsinsky is investigating the Board of Directors of Plains Exploration & Production Company (NYSE: PXP) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Freeport-McMoRan Copper & Gold Inc. (NYSE: FCX) under which PXP shareholders will receive 0.6531 shares of FCX common stock and $25.00 in cash per share.Click here to learn more: http://zlk.9nl.com/plains-exploration-pxp.  (Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )Intermec Inc. Levi & Korsinsky is investigating the Board of Directors of Intermec Inc. (NYSE: IN) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Honeywell Interntaional Inc. ("Honeywell") (NYSE: HON) for $10 per share.Click here to learn more about the investigation: http://9nl.com/intermec/, or call: 877-363-5972.TNS, Inc. Levi & Korsinsky is investigating the Board of Directors of TNS, Inc. (NYSE: TNS) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Siris Capital Group for $21 per share. At least one analyst set a price target for TNS stock at $27.50 per share.Click here to learn more about the investigation: http://zlk.9nl.com/tns/, or call: 877-363-5972.Somaxon Pharmaceuticals, Inc. Levi & Korsinsky is investigating the Board of Directors of Somaxon Pharmaceuticals, Inc. (NasdaqCM: SOMX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Pernix Therapeutics Holdings, Inc. (NYSE MKT: PTX).Click here to learn more about the investigation: http://zlk.9nl.com/somaxon-pharmaceuticals-somx/, or call: 877-363-5972.Levi & Korsinsky is a national firm with offices in New York and Washington D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:     Levi & Korsinsky, LLP Joseph Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free:  (877) 363-5972 Fax: (866) 367-6510 www.zlk.com SOURCE Levi & Korsinsky, LLP